A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics
Clinical trial NCT06213844 · COMPLETED
Trial details
- NCT number
- NCT06213844
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-26
- Primary completion
- 2025-07-22
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.